2025-05-02 09:12:10
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Venus Remedies Ltd Q3FY22 consolidated net profit slides to Rs. 5.64 crores
Posted On : 2022-01-31 23:22:53( TIMEZONE : IST )
Venus Remedies Limited has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 125.560 crores during the period ended December 31, 2021 as compared to Rs. 205.450 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 5.646 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 23.148 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 4.22 for the period ended December 31, 2021 as compared to Rs. 17.32 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹125.560 crs | ₹205.450 crs |  -38.89% |
| Net Profit | ₹5.646 crs | ₹23.148 crs | -75.61% |
| EPS | ₹4.22 | ₹17.32 | -75.64% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs.125.560 crores during the period ended December 31, 2021 as compared to Rs.123.765 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.5.646 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.11.655 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.4.22 for the period ended December 31, 2021 as compared to Rs.9.44 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹125.560 crs | ₹123.765 crs |  1.45% |
| Net Profit | ₹5.646 crs | ₹11.655 crs | -51.56% |
| EPS | ₹4.22 | ₹9.44 | -55.30% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.462.775 crores during the 9 Months period ended December 31, 2021 as compared to Rs.452.890 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.40.491 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.26.656 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.30.68 for the 9 Months period ended December 31, 2021 as compared to Rs.21.60 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹462.775 crs | ₹452.890 crs | 2.18% |
| Net Profit | ₹40.491 crs | ₹26.656 crs | 51.90% |
| EPS | ₹30.68 | ₹21.60 | 42.04% |
Shares of Venus Remedies Limited was last trading in BSE at Rs. 340.35 as compared to the previous close of Rs. 349.40. The total number of shares traded during the day was 16231 in over 1420 trades.
The stock hit an intraday high of Rs. 372.05 and intraday low of 329.90. The net turnover during the day was Rs. 5588471.00.
